ResMed Inc. (RMD): Price and Financial Metrics
GET POWR RATINGS... FREE!
RMD Price/Volume Stats
Current price | $215.44 | 52-week high | $247.65 |
Prev. close | $216.97 | 52-week low | $194.30 |
Day low | $214.79 | Volume | 698,700 |
Day high | $218.44 | Avg. volume | 595,124 |
50-day MA | $223.73 | Dividend yield | 0.81% |
200-day MA | $221.34 | Market Cap | 31.65B |
RMD Stock Price Chart Interactive Chart >
RMD POWR Grades
- Sentiment is the dimension where RMD ranks best; there it ranks ahead of 90.07% of US stocks.
- RMD's strongest trending metric is Growth; it's been moving up over the last 179 days.
- RMD's current lowest rank is in the Momentum metric (where it is better than 15.05% of US stocks).
RMD Stock Summary
- RMD has a higher market value than 93.07% of US stocks; more precisely, its current market capitalization is $32,383,517,464.
- Price to trailing twelve month operating cash flow for RMD is currently 60.49, higher than 93.8% of US stocks with positive operating cash flow.
- The volatility of RESMED INC's share price is greater than that of merely 0.52% US stocks with at least 200 days of trading history.
- Stocks with similar financial metrics, market capitalization, and price volatility to RESMED INC are A, HOLX, TEL, HZNP, and HPE.
- RMD's SEC filings can be seen here. And to visit RESMED INC's official web site, go to www.resmed.com.
RMD Valuation Summary
- In comparison to the median Healthcare stock, RMD's price/earnings ratio is 57.26% higher, now standing at 37.9.
- RMD's price/sales ratio has moved up 2.9 over the prior 243 months.
Below are key valuation metrics over time for RMD.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
RMD | 2023-05-23 | 8.1 | 8.3 | 37.9 | 31.1 |
RMD | 2023-05-22 | 8.2 | 8.4 | 38.4 | 31.4 |
RMD | 2023-05-19 | 8.2 | 8.4 | 38.2 | 31.3 |
RMD | 2023-05-18 | 8.2 | 8.4 | 38.2 | 31.3 |
RMD | 2023-05-17 | 8.2 | 8.4 | 38.1 | 31.3 |
RMD | 2023-05-16 | 8.4 | 8.5 | 38.9 | 31.9 |
RMD Growth Metrics
- The 4 year net income to common stockholders growth rate now stands at 53.62%.
- The 4 year price growth rate now stands at 133.96%.
- Its year over year cash and equivalents growth rate is now at -12.52%.

The table below shows RMD's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 3,763.275 | 370.223 | 809.465 |
2022-09-30 | 3,624.405 | 461.466 | 786.302 |
2022-06-30 | 3,578.127 | 351.147 | 779.437 |
2022-03-31 | 3,539.492 | 498.186 | 779.476 |
2021-12-31 | 3,443.759 | 577.025 | 521.983 |
2021-09-30 | 3,348.896 | 527.062 | 499.746 |
RMD's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- RMD has a Quality Grade of C, ranking ahead of 68.39% of graded US stocks.
- RMD's asset turnover comes in at 0.72 -- ranking 50th of 186 Medical Equipment stocks.
- PEYE, MMSI, and SIEN are the stocks whose asset turnover ratios are most correlated with RMD.
The table below shows RMD's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.720 | 0.569 | 0.426 |
2021-06-30 | 0.691 | 0.575 | 0.410 |
2021-03-31 | 0.673 | 0.582 | 0.379 |
2020-12-31 | 0.676 | 0.582 | 0.342 |
2020-09-30 | 0.670 | 0.583 | 0.321 |
2020-06-30 | 0.672 | 0.581 | 0.300 |
RMD Price Target
For more insight on analysts targets of RMD, see our RMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $261.67 | Average Broker Recommendation | 1.91 (Hold) |
ResMed Inc. (RMD) Company Bio
ResMed is a San Diego, California-based medical device company. It primarily provides cloud-connectable CPAP devices and masks for the treatment of sleep apnea, as well as devices and masks for treating chronic obstructive pulmonary disease (COPD), neuromuscular disease, and other respiratory-related conditions. It also provides a self-monitoring digital sensor and app for people who use inhalers to treat COPD or asthma via Propeller Health, which ResMed acquired in 2019. (Source:Wikipedia)
Latest RMD News From Around the Web
Below are the latest news stories about RESMED INC that investors may wish to consider to help them evaluate RMD as an investment opportunity.
Billionaire Ken Griffin’s 2023 Portfolio: Top 15 Stock PicksIn this piece, we will take a look at the top fifteen stocks in billionaire Ken Griffin’s 2023 portfolio. For more stocks, head on over to Billionaire Ken Griffin’s 2023 Portfolio: Top 5 Stock Picks. The stock market crash of 2022 hammered several major hedge funds. One of the biggest funds that bled capital last […] |
ResMed Inc. (NYSE:RMD) is favoured by institutional owners who hold 74% of the companyKey Insights Given the large stake in the stock by institutions, ResMed's stock price might be vulnerable to their... |
With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting CaseFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to... |
ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality OfficerRider and Haake, both internal promotions, joined ResMed’s executive team on May 1Rider, currently Senior Vice President, Deputy Global General Counsel will succeed retiring Chief Administrative Officer, Global General Counsel, and Secretary David Pendarvis on July 1 SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced the appointment of two new executive team members: Michael Rider, Global General Counsel & Secretary, effective July 1, 2023, and Dawn Haake as |
Sleep-Apnea Growth Stock Breaks Out On Record Earnings; Device Sales SurgeGrowth stock and sleep-apnea device maker ResMed broke out Friday after quarterly earnings continued to accelerate. Shares surged above an entry at 227.94 from a cup with handle in strong volume and are in a buy zone, according to IBD MarketSmith. |
RMD Price Returns
1-mo | -10.42% |
3-mo | 1.87% |
6-mo | -3.10% |
1-year | 4.24% |
3-year | 38.76% |
5-year | 123.34% |
YTD | 3.91% |
2022 | -19.47% |
2021 | 23.41% |
2020 | 38.33% |
2019 | 37.85% |
2018 | 36.38% |
RMD Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching RMD
Want to do more research on Resmed Inc's stock and its price? Try the links below:Resmed Inc (RMD) Stock Price | Nasdaq
Resmed Inc (RMD) Stock Quote, History and News - Yahoo Finance
Resmed Inc (RMD) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...